Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hefei Enrit Pharmaceutical
Hefei, Anhui Sheng, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Hefei Enrit Pharmaceutical is a private Chinese pharmaceutical company focused on the development and commercialization of small molecule drugs. The company has at least one approved product for allergic rhinitis targeting the Histamine H1 receptor and is involved in clinical development of other small molecules, including teriflunomide targeting DHODH[1][6]. Clinical results include bioequivalence studies for memantine hydrochloride orodisintegrating tablets[1].
- Therapeutic areas
- ImmunologyNeurologyInfectious Diseases
- Modalities
- Small molecule
- Industry
- Biotech
Beyond the preview
Go deeper on Hefei Enrit Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hefei Enrit Pharmaceutical.